DalsnaFinance › IPOs › Aligos Therapeutics › IPO
Aligos Therapeutics, Inc. completed its initial public offering on NASDAQ on October 16, 2020, pricing at $15.00 a share.
| Ticker | ALGS |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 16, 2020 |
| Offering price | $15.00 |
| Shares offered | 10,000,000 |
| Total raised | $150M |
Aligos Therapeutics, Inc. sold 10,000,000 shares at $15.00 each on NASDAQ. Multiplied out, that is $150 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $150 million total recorded for the deal.
Aligos Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Aligos Therapeutics, Inc.. This page is general information, not investment advice.